Historique
Rapport
Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 2 : Drug treatment for preventing hepatitis C, HIV and injecting risk behaviour
Accompagne :
Article en page(s) :
43 p.
Sous-type de document :
Revue de la littérature / Literature review
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
EFFICACITE
;
INTERVENTION
;
PREVENTION
;
INFECTION
;
USAGER
;
HEPATITE
;
VIH
;
TRAITEMENT
;
INJECTION
;
PHARMACOTHERAPIE
;
OPIACES
;
TRAITEMENT DE MAINTENANCE
;
SUBSTITUTION
;
EVALUATION
Résumé :
The aim of the literature review presented in this report was to provide evidence to inform the recommendations made by ECDC and the EMCDDA in the 2011 'Guidance on the prevention and control of infectious diseases among people who inject drugs'.
The evidence presented here focuses on the effectiveness of drug treatment on the occurrence and risk of hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV); the progression of HIV; and/or injecting risk behaviour in people who inject drugs. Additional evidence on the effectiveness of drug treatment is covered in a companion technical report 'Evidence for the effectiveness of interventions to prevent infections among people who inject drugs, Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour'.
The evidence included here is based on research published in the literature: this report does not present exhaustive evidence for effectiveness of public health interventions, as different types of evidence may be considered, such as evidence based on expert opinion or stemming from 'best implementation practices'. There are also other reasons for providing some of the interventions reviewed here, such as to attract and attach users to services and, while such outcomes were out of the scope of this review, these factors may provide rationale to include certain interventions as part of successful multi-component intervention programmes, even in the absence of their effectiveness in decreasing hepatitis C, HIV, and injecting-risk behaviour.
The evidence presented here focuses on the effectiveness of drug treatment on the occurrence and risk of hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV); the progression of HIV; and/or injecting risk behaviour in people who inject drugs. Additional evidence on the effectiveness of drug treatment is covered in a companion technical report 'Evidence for the effectiveness of interventions to prevent infections among people who inject drugs, Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour'.
The evidence included here is based on research published in the literature: this report does not present exhaustive evidence for effectiveness of public health interventions, as different types of evidence may be considered, such as evidence based on expert opinion or stemming from 'best implementation practices'. There are also other reasons for providing some of the interventions reviewed here, such as to attract and attach users to services and, while such outcomes were out of the scope of this review, these factors may provide rationale to include certain interventions as part of successful multi-component intervention programmes, even in the absence of their effectiveness in decreasing hepatitis C, HIV, and injecting-risk behaviour.
Titre précédent :
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |